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Edited by Robert BaroukiAbstract Processes maintaining protein homeostasis in the cell
are governed by the activities of molecular chaperones that
mainly assist in the folding of polypeptide chains and by a large
class of proteases that regulate protein levels through degrada-
tion. ClpP proteases deﬁne a distinctive family of cylindrical, en-
ergy-dependent serine proteases that are highly conserved
throughout bacteria and eukaryota. They typically interact with
ATP-dependent AAA+ chaperones that bind and unfold target
substrates and then translocate them into ClpP for degradation.
Structural and functional studies have provided a detailed view of
the mechanism of function of this class of proteases.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Proteases play an essential role in protein quality control by
removing short-lived regulatory proteins, as well as proteins
that are misfolded and damaged, thus maintaining cellular
homeostasis. A signiﬁcant proportion of protein degradation
in the cell is carried out by oligomeric, cylindrical, self-com-
partmentalized, energy-dependent proteases. Caseinolytic pro-
tease (ClpP) is a representative member of these cylindrical
proteases. Other members include HslV and the 20S protea-
some core particle.
ClpP is a highly conserved serine protease present through-
out bacteria and eukaryota; it seems to be absent in archaea
[1], mollicutes [1], and some fungi (Table 1). ClpP was ﬁrst
identiﬁed in Escherichia coli [2,3], and more than 400 studies
have been published on it since its discovery. The X-ray struc-
ture of ClpP has been solved from several diﬀerent organisms
(Figs. 1 and 2). All the structures show similar features: the
protease is comprised of 14 subunits arranged into two hepta-
meric rings forming a cylindrical-like structure which encloses
a large chamber containing the protease active sites. Entrance
into the chamber occurs through axial pores in the cylinder.
ClpP typically forms complexes with AAA+ (ATPases associ-
ated with various cellular activities) chaperones that denature
substrates and then translocate them through the axial pores
into the proteolytic chamber of the protease for degradation.*Corresponding author. Fax: +1 416 978 8548.
E-mail address: walid.houry@utoronto.ca (W.A. Houry).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.04.076ClpP degrades proteins into peptides of about 7–8 residues
[4], which are subsequently released from the chamber.
In this review, we will describe the distribution of Clp
proteases in diﬀerent kingdoms of life and then discuss in more
detail ClpP structure and mechanism of function.2. The distribution of ClpP proteases in diﬀerent kingdoms of life
2.1. Bacterial ClpPs
ClpP is found in all bacteria sequenced to date except for
Mollicutes [5]. Table 1 lists the number of ClpP copies present
in selected organisms. The majority of bacteria contain only
one copy of ClpP, although there are exceptions such as for
actinobacteria, chlamydiae, cyanobacteria, and others (Table
1) which have multiple isoforms of the protease. In addition
to ClpP, cyanobacteria contain a ClpP paralog that does not
have all three residues of the Ser-His-Asp catalytic triad. This
inactive version of ClpP is called ClpR and is mostly present
in plants [6] in addition to cyanobacteria. For example, cyano-
bacteria Synechococcus elongatus and Synechocystis PCC6803
contain three copies of ClpP and one copy of ClpR (Table 1
and Fig. 3) [7,8].
ClpP was ﬁrst identiﬁed and mostly studied in Escherichia
coli, which contains only one copy of the protease (Table 1).
E. coli ClpP consists of 207 amino acids including an N-termi-
nal prosequence which acts as a regulatory peptide and under-
goes autocatalytic cleavage during folding to yield a mature
ClpP of 193 residues [9]. In E. coli, ClpP forms complexes with
AAA+ chaperones, ClpX and ClpA, which belong to the Clp/
Hsp100 family. ClpA is an 83 kDa ATPase that contains two
AAA+ domains, while ClpX contains only one AAA+ domain
(46 kDa), which is homologous to the second AAA+ domain
of ClpA. ClpA and ClpX are hexameric chaperones that can
stack onto one or both ends of ClpP to form ClpAP or ClpXP
holoenzyme complexes. Substrates are recognized, unfolded by
ClpX or ClpA, and then threaded into the ClpP proteolytic
chamber through the narrow axial pores for degradation
(Fig. 4). Only the unfolding and threading by the chaperones
require ATP binding and hydrolysis, while proteolysis by ClpP
does not require nucleotide hydrolysis. The mechanism by
which ClpX or ClpA binds to and unfolds substrates is poorly
understood. Other bacteria contain ClpA paralogs, such as
ClpC, ClpE, and ClpL [10].
The most general substrates for the E. coli ClpXP or ClpAP
system are those with an SsrA C-terminal tag [11]. The SsrA
tag consists of 11 hydrophobic residues that are added by a
tmRNA, also called SsrA or 10Sa RNA, to the C-terminusblished by Elsevier B.V. All rights reserved.
Table 1
The distribution of ClpP and ClpR across diﬀerent organisms
Superkingdom Phylum Class Species ClpP ClpR
Archaea 32 completely sequenced genomes
Bacteria Actinobacteria Actinobacteria Mycobacterium tuberculosis H37Rv 2
Bacteroidetes Bacteroidetes Bacteroides fragilis NCTC 9343 1
Chlorobi Chlorobia Chlorobium chlorochromatii CaD3 1
Chlamydiae Chlamydiae Chlamydia muridarum Nigg 2
Chlamydiae Chlamydiae Chlamydophila pneumoniae AR39 2
Cyanobacteria – Prochlorococcus marinus str. MIT 9313 3 1
Cyanobacteria – Synechococcus elongatus 3 1
Cyanobacteria – Synechocystis PCC6803 3 1
Firmicutes Clostridia Carboxydothermus hydrogenoformans Z-2901 1
Firmicutes Bacilli Bacillus subtilis str.168 1
Firmicutes Bacilli Streptococcus pneumoniae R6 1
Firmicutes Bacilli Lactobacillus acidophilus NCFM 1
Firmicutes Mollicutes 16 completely sequenced genomes
Spirochaetes Spirochaetes Borrelia afzelii (strain PKo) 2
Proteobacteria Alphaproteobacteria Agrobacterium tumefaciens str. C58 3
Proteobacteria Alphaproteobacteria Anaplasma phagocytophilum HZ 1
Proteobacteria Alphaproteobacteria Rickettsia felis URRWXCal2 1
Proteobacteria Betaproteobacteria Bordetella pertussis Tohama I 1
Proteobacteria Betaproteobacteria Bordetella parapertussis 12822 1
Proteobacteria Betaproteobacteria Burkholderia cenocepacia AU 1054 1
Proteobacteria Betaproteobacteria Ralstonia eutropha JMP134 1
Proteobacteria Betaproteobacteria Chromobacterium violaceum ATCC 12472 1
Proteobacteria Betaproteobacteria Neisseria gonorrhoeae FA 1090 1
Proteobacteria Betaproteobacteria Neisseria meningitidis FAM18 1
Proteobacteria Deltaproteobacteria Desulfotalea psychrophila LSv54 1
Proteobacteria Deltaproteobacteria Geobacter metallireducens GS-15 1
Proteobacteria Epsilonproteobacteria Campylobacter jejuni RM1221 1
Proteobacteria Epsilonproteobacteria Helicobacter pylori J99 1
Proteobacteria Gammaproteobacteria Escherichia coli K12 1
Proteobacteria Gammaproteobacteria Salmonella typhimurium LT2 1
Proteobacteria Gammaproteobacteria Yersinia pestis Antiqua 1
Proteobacteria Gammaproteobacteria Haemophilus ducreyi 35000HP 1
Proteobacteria Gammaproteobacteria Pasteurella multocida subsp. Multocida str. Pm70 1
Proteobacteria Gammaproteobacteria Pseudomonas aeruginosa 2192 2
Proteobacteria Gammaproteobacteria Vibrio cholerae O1 biovar eltor str. N16961 1
Proteobacteria Gammaproteobacteria Xanthomonas axonopodis pv. citri str. 306 1
Eukaryota Apicomplexa Aconoidasida Plasmodium falciparum 3D7 1 1
Ascomycota Saccharomycetes Saccharomyces cerevisiae
Ascomycota Schizosaccharomycetes Schizosaccharomyces pombe 972h-
Ascomycota Sordariomycetes Gibberella zeae PH-1 (incomplete sequence) 1
Ascomycota Sordariomycetes Neurospora crassa OR74A (incomplete sequence) 1
Ascomycota Eurotiomycetes Aspergillus fumigatus Af293 1
Chlorophyta Chlorophyceae Chlamydomonas reinhardtii 4 5
Streptophyta – Arabidopsis thaliana 6 4
Nematoda Chromadorea Caenorhabditis elegans 1
Arthropoda Insecta Drosophila melanogaster 1
Chordata Mammalia Mus musculus 1
Chordata Mammalia Rattus norvegicus 1
Chordata Mammalia Homo sapiens 1
E. coli ClpP, Synechocystis PCC6803 ClpR, and Arabidopsis ClpR protein sequences were used to BLAST against all archaeal genomes up to date
(NCBI March, 2007 version) and selected organisms from bacteria and eukaryota in NCBI. A cut-oﬀ of 40% identity with at least 150 amino acids
aligned was typically used. The results for Chlamydomonas reinhardtii are based on published literature [29].
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targeting them for degradation [12–14].
Without ATPase components, only small peptides can enter
the ClpP chamber [15,16]; hence, ClpP on its own cannot de-
grade folded proteins. Recently, however, a group at Bayer de-
scribed the discovery of acyldepsipeptides (ADEPs) that, when
added to ClpP, allow the protease to degrade folded native
proteins in the absence of its cognate chaperones [17]. The
drug was initially found to rescue mice challenged with lethal
infections of Enterococcus faecalis and Staphylococcus aureus,
and the target for the drug was then identiﬁed to be ClpP.ClpP is activated by ADEPs to degrade, or at least to cleave,
folded proteins in the absence of the cognate Clp ATPases.
The consequences of the action of the drug in vivo, is that
the ADEPs cause unregulated proteolysis by ClpP, subse-
quently, triggering cell death in Gram-positive bacteria.
Gram-negative bacteria, on the other hand, were found to be
able to survive drug treatment because they have eﬃcient eﬄux
pumps to remove the drug from the cell, but deletion of those
pumps or the use of permeabilizing agents made Gram-
negative bacteria vulnerable to ADEP treatment as well [17].
The mechanism of how ADEPs activate ClpP in the absence
Fig. 1. The structures of tetradecameric ClpP. Shown are the side and top views of the X-ray structures of tetradecameric ClpPs from E. coli (1YG6),
S. pneumoniae (1Y7O), M. tuberculosis (2CE3), P. falciparum (2F6I), and human (1TG6). The structures were drawn using PyMOL (http://
pymol.sourceforge.net/).
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of ADEPs may lead to development of a novel class of antimi-
crobial agents.
2.2. Human ClpP
In the human genome, ClpP is encoded on chromosome 19
[18]. Immunoﬂuorescence studies illustrated that human ClpP
is located in the mitochondrial matrix [19], although its role is
still not known. The mature human ClpP has about 56 residues
removed from its N-terminus [19,20], which include the mito-
chondrial targeting sequence and the prosequence. Mature
human ClpP shares high sequence identity (56%) and similarity
(71%) with E. coli ClpP (Fig. 3), however, human ClpP has an
additional 28 residues present at its C-terminus. The function
of the extended C-terminus is unknown although it seems to
be a unique feature of mammalian ClpPs [21]. The only ATP-
ase component identiﬁed so far for human ClpP is ClpX,
which is encoded on chromosome 15 [18]. Human ClpX also
contains an extended N-terminal sequence which targets ClpX
to the mitochondria; the mature human ClpX shares 44% iden-
tity and 62% similarity with E. coli ClpX.
Unlike E. coli ClpP that exists solely as a double-ring tetra-
decamer, human ClpP exists as a single heptameric ring under
physiological conditions [22]. In E. coli, the ClpP catalytic tri-
ads are compartmentalized inside two heptameric rings (Figs. 1
and 2), but in the human single-ring ClpP, they are exposed to
the environment. Indeed, the active sites in human ClpP have
been shown to be solvent accessible by trypsin digestion [23].
The accessible catalytic triads would be detrimental for the cell
if they are in an active conﬁguration. However, the heptameric
human ClpP does not exhibit protease activity and has a very
low peptidase activity compared to E. coli ClpP [23]. The lack
of activity is likely due to an inactive orientation of the cata-lytic triads in human ClpP heptamer, which might result from
the higher mobility in the handle region in the heptameric sin-
gle ring assembly compared to the tetradecameric double-ring
complex. The catalytic triad is located at the interface between
the handle and head regions (Fig. 2A) and, hence, high mobil-
ity in the handle region is expected to disrupt the proper orien-
tation of the catalytic triad.
The single-ring human ClpP forms a double ring upon bind-
ing to ClpX in the presence of ATP, which suggests that bind-
ing of the ATPase component might induce conformational
changes in the ClpP heptameric rings leading to the formation
of the double ring. The human ClpXP complex has protease
activity as well as higher peptidase activity compared to hepta-
meric human ClpP, implying that the catalytic residues are
properly oriented in an active conﬁguration to catalyze peptide
bond hydrolysis [23]. Hence, in the human ClpP heptamer, the
accessible catalytic sites are inactive to prevent uncontrolled
proteolysis until the ClpP cylinder is properly formed and
the active sites are sequestered from the environment upon
binding of ClpX and the formation of ClpXP complexes. Such
a paradigm of functional regulation has been observed for
ClpPs in other organisms such as Bacillus subtilis [24].
Surprisingly, it was found that human ClpP can form a com-
plex with E. coli ClpX in vitro [22]. The structure of the heter-
ogeneous complex as visualized by electron microscopy was
highly similar to that of the E. coli ClpXP complex. However,
the inverse hetero-complex of human ClpX and E. coli ClpP
could not be formed. Also, the E. coli ClpA ATPase has no
aﬃnity to human ClpP. It is known that human ClpXP does
not recognize the same substrates as the E. coli ClpXP system.
Interestingly, however, when human ClpP is associated with
E. coli ClpX, the heterogeneous system can degrade E. coli
ClpXP substrates. These data further conﬁrm that substrate
Fig. 2. The structures of the ClpP subunit. (A) Secondary structure elements of E. coli ClpP monomer are highlighted, the axial loops, head domain,
and handle region are also indicated. Residues of the catalytic triad are shown as dotted spheres. (B)–(F) Overlay of the monomers from S.
pneumoniae (1Y7O),M. tuberculosis (2CE3), P. falciparum (2F6I), and human (1TG6) ClpPs with that from E. coli ClpP (1YG6). The overlays were
done using PyMOL. The S. pneumoniae ClpP has the mutation A153P in the E helix.
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the system.
2.3. Plant ClpPs
The diversity and complexity of the Clp family is evident in
higher plant organisms [25]. There are at least 10 ClpP-like
proteins identiﬁed in the model plant Arabidopsis thaliana
[26] (Table 1). There are 6 ClpP paralogs (ClpP1–6) and 4
ClpR paralogs (ClpR1–4). Phylogenetic studies indicate that
some ClpR proteins (ClpR1, 3, 4) of Arabidopsis thaliana
may have evolved from the cyanobacterial ClpR [6]. In addi-
tion, there are 10 Clp/Hsp100 AAA+ chaperones found in
A. thaliana including 7 Class I (ClpB1–4, ClpC1–2, ClpD)
and 3 Class II (ClpX1-3) which are associated with ClpPR
complexes [25]. ClpT is an ortholog of the bacterial ClpS,
which is a cofactor that binds to ClpA and aﬀects substrate
speciﬁcity in E. coli [27]. A new group of plant Clp chaperones
with unknown function were discovered and also named as
ClpS (ClpS1, ClpS2), but they have no similarity with bacterial
ClpS and should not be confused with them. Although the
function of plant ClpS1-2 is not clear, their sequences are
homologous to the N-terminus of the chaperone ClpC but lack
the AAA+ domains [6], which led to the suggestion that they
may bind to the apical surface of ClpPR core complex, pre-
venting association with the ATPases [25].Most Clp ATPases and proteases in Arabidopsis are found in
the chloroplast stroma including ClpB3, ClpC1–2, ClpD,
ClpP1, CpP3–6, ClpR1–4, ClpS1–2, and ClpT. All of them
are encoded in the nuclear genome, except for ClpP1 which
is plastid-encoded [25,26]. The complexity of Clp proteins
was also seen in other plants. For example, all Clp proteins ex-
cept for ClpT were also identiﬁed in the plastids of non-green
plants Brassica rapa roots and Brassica oleracea petals by mass
spectrometry [6,25].
The ClpP oligomer in the chloroplast of Arabidopsis has
been identiﬁed as composed of the subunits ClpP1, ClpP3–6,
ClpR1–4 and ClpS1–2, forming a complex of 325–350 kDa
[25]. Modeling studies indicate that ClpP and ClpR contribute
to formation of the tetradecamer, whereas ClpS1–2 do not ﬁt
in the ring structure but rather seem to be associated with
hydrophobic pockets on the axial sites on top of the ClpPR
core complex [25]. In the mitochondria, the ClpP complex is
a homotetradecamer of ClpP2 subunits [25,26]. From sequence
alignments, ClpP2 is found to be the most closely related to
human mitochondrial ClpP, and, hence, mitochondrial plant
ClpP2 possibly forms a complex with plant ClpX which is also
targeted to the plant mitochondria [28].
ClpS1-2 are only found in land plants but not in prokaryotes
or green algae, which suggests that they probably have special
functional roles in proteolysis in higher plants. Binding of
Fig. 3. Alignment of ClpP and ClpR sequences. Sequence alignments of ClpP from E. coli, S. pneumoniae,M. tuberculosis, P. falciparum, and human
with ClpR from Synechocystis PCC6803 and ClpR3 from A. thaliana. The alignment was generated using ClustalW and the Blosum62 matrix [49].
Identical residues in all seven sequences are highlighted in green, while identical residues in the ﬁve ClpP sequences are highlighted in yellow. The
catalytic triad residues are indicated by blue dots. The boundaries for the axial loop and handle region and the numbering of the helices and strands
refer to that of E. coli ClpP [34,37].
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binding of the cognate ATPase such as ClpC or ClpD. There-
fore ClpS1–2 might regulate degradation by competitive bind-
ing with the ATPase chaperones [29]. The heterocomplex of
ClpPR core is also found in the green alga Chlamydomonas
reinhardtii stroma (also see Table 1), but ClpS1–2 do not exist
in C. reinhardtii genome [25]. Instead, a 30-kDa insertion se-
quence (IS1) is found in ClpP1 of C. reinhardtii, which is pro-
posed to have the same eﬀect as ClpS1–2. The insertion
domain located between helix 2 and strand 2 (Fig. 2) should
protrude over the apical surface thus hindering ATPase bind-
ing [29].
The inactive ClpR is thought to have a regulatory role in
proteolysis. ClpRs in A. thaliana have extended C-termini
compared to E. coli ClpP (Fig. 3). The C-terminal extension
in ClpR might fold on top of the proteolytic core and, hence,
might control the interaction between the core and its chaper-
ones. An insertion loop of 9–10 residues in ClpR1, ClpR3, and
ClpR4 is found when aligned with A. thaliana ClpPs. Accord-
ing to homology modeling, the insertion loop is part of thesubstrate-binding cleft in the active site, thus this loop of the
non-catalytic ClpR proteins might participate in presenting
substrates to the catalytic triads of active ClpP neighbors [25].
The cellular functions of most ClpPs in plants are not yet
known, but all ClpP paralogs are essential for chloroplast
development. In C. reinhardtii, ClpP1 is responsible for
degrading fully or incompletely assembled cytochrome b6f
and for high CO2 tolerance [30]. ClpP1 is also vital for plastid
development and plant viability in tobacco (Nicotiana taba-
cum) [31,32]. In Arabidopsis, ClpR2 is essential for Clp core
complex assembly since reducing the levels of ClpR2 resulted
in reduction of the ClpPRS protease complex levels, which
led to a pale-green phenotype, delayed shoot development, re-
duced chloroplast size, decreased thylakoid accumulation, and
increased plastoglobule levels [33].
In summary, the plant Clp system is much more complicated
than in other organisms. This might be a reﬂection of the mul-
tiple severe stresses that stationary organisms encounter.
Studying the plant Clps is a new and exciting area of research
that is still at its infancy and needs to be further explored.
Native protein
ClpP
release of
peptides
Chaperone
Chaperone
1. capture and unfolding of native protein by cognate chaperone
2. translocation of unfolded protein into ClpP
3. degradation of unfolded protein
4. release of peptide fragments
axial loops 
Native protein
Fig. 4. Model of ClpP mechanism of function. Shown is a cartoon model of the ClpP tetradecamer with the axial loops indicated. For simplicity, the
chaperones bound to ClpP are drawn as simple ellipses. In the proposed model, substrate proteins are unfolded and then translocated into the ClpP
cylinder by the bound chaperone. Unfolded polypeptides enter the ClpP proteolytic chamber through the axial pores which are lined by the axial
loops. The polypeptide chains are then degraded into small peptides. The peptides are proposed to be released through axial pores that are transiently
formed as a result of the dynamics in the handle region of the ClpP subunits.
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In yeast, ClpP homologs are found in some but not all
strains. There are no ClpP sequences identiﬁed in the common
laboratory strains of Saccharomyces cerevisiae and Schizosac-
charomyces pombe (Table 1). However, Gibberella zeae, Neu-
rospora crassa, and Aspergillus fumigatus, among others,
contain ClpP-like proteins that typically have sequences short-
er than that of E. coli ClpP. Multiple sequence alignment re-
veals that the yeast ClpPs have about 50–70 residues deleted
from their N-termini when compared to E. coli ClpP. Little
is known about the cellular function of these yeast ClpPs or,
indeed, whether these shorter ClpPs are active.3. ClpP structure and function
3.1. ClpP X-ray structure
To date, ClpP structures have been solved from ﬁve diﬀerent
organisms (Fig. 1) including E. coli [34–36], Streptococcus
pneumoniae [37], the malaria agent Plasmodium falciparum
[38], Mycobacterium tuberculosis [39], and human [21]. The se-
quence alignment of these diﬀerent ClpPs is given in Fig. 3. As
expected, the overall ClpP structures from these organisms are
very similar (Figs. 1 and 2).
The X-ray structure of ClpP from E. coli was the ﬁrst to be
solved (1TYF) [34]; it shows a cylindrical-shaped tetradecamer
of about 300 kDa in molecular weight and 90 A˚ in both height
and diameter [34]. The monomer (Fig. 2) is mainly composed
of six repeats of a/b-fold (aA/b1/b2, aB/b3/b4, aC/b5/b6, aD/
b7/b8, aF/b10, and aG/b11) with an additional protruding a/
b unit (aE/b9). The subunits are held together mainly by
hydrophobic interactions. Each monomer can be divided into
a handle region (b strand 9 and E helix), which mediates ring-ring interaction, and a head domain comprised of residues 42–
134 and 174–202 [34]. A heptameric ring is formed from the
packing of head domains, exposing 7 handle regions, which
intercalate with seven handle regions from the opposite hepta-
meric ring, forming a tetradecamer with a spherical internal
chamber of about 51 A˚ in diameter [40]. Although according
to the X-ray structure, the handle region is the only area where
two ClpP rings have contact, surprisingly, truncations in this
region do not lead to the dissociation of the 2 rings, indicating
a high degree of plasticity of this region [37]. Charge–charge
interaction networks involving residues in the head domain
seem to contribute to stabilizing the interactions between the
two ClpP heptameric rings [37,41]. The two rings are found
to dissociate under high sulfate concentration at low tempera-
ture [41].
A mutant ClpP(A153P) from S. pneumoniae was solved
(Figs. 1and 2) and the major diﬀerence in the structure of this
mutant from the ﬁrst solved E. coli ClpP was in the N-terminal
region. In S. pneumoniae ClpP(A153P), it was observed that
the N-terminal residues Met16-Ser30 (using E. coli SwissProt
numbering, Fig. 3) form an extended loop protruding from
the body of the ClpP cylinder. These axial loops were not de-
tected in the original E. coli ClpP structure due to the weak
electron density in that region. However, recently solved
X-ray structures of E. coli ClpP (e.g. 2FZS [36] and 1YG6
[35], shown in Fig. 1) and human ClpP (1TG6) [21] show the
presence of these axial loops. These axial loops are an
important feature of the ClpP structure and have been shown
to mediate the interaction of ClpP with its cognate ATPases
[37].
The mutation of Ala153 to Pro in the S. pneumoniae
ClpP(A153P) structure causes disorder in the handle domain
and renders the E helix shorter by two turns as compared to
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ClpP remains tetradecameric under these conditions is an
explicit demonstration of the plasticity of the handle region.
This region is also found to be disordered in the crystal struc-
ture of P. falciparum ClpP and M. tuberculosis ClpP1. Based
on biochemical and NMR-based studies [37,42], we had pro-
posed that this region of ClpP is highly dynamic and that
the movement of the E helices results in the transient forma-
tion of equatorial side pores that allow for the exit of peptide
fragments generated from the degradation of polypeptide
chains inside the ClpP chamber (Fig. 4). This issue is further
discussed below.
Very little is known about the P. falciparum ClpP. However,
the sequence of this protease has about 150 extra amino acids
at the N-terminus of the protein when compared to the se-
quence of the E. coli ClpP. It is predicted that this extra N-ter-
minal sequence targets the nuclear encoded protease to the
apicoplast organelle present in plasmodium, although this
has not been experimentally demonstrated. The apicoplast is
an organelle that is homologous to chloroplast of plants and
is found in apicomplexan parasites such as P. falciparum
[43]. The apicoplast is an ancient feature of this group of
organisms and is thought to have been acquired by the process
of endosymbiosis. It contains proteins that are nuclear en-
coded and then transported to this organelle and also proteins
that are encoded and expressed by its own genome and expres-
sion machinery.
The structure of M. tuberculosis ClpP1 has two unique fea-
tures [39]. First, there is an extended aA helix at the N-termi-
nus (Fig. 2) which renders the axial pores smaller compared to
those in other ClpPs. Second, the monomers are tilted inwards
compared to other ClpPs. The rotated orientation of the
monomers results in equatorial side pores, which were sug-
gested to transiently form in ClpP [37,42]. This rotated orien-
tation of the monomers may assist in substrate entry through
the axial pores, or product release from the equatorial pores
[39]. Like human ClpP, M. tuberculosis ClpP1 is also found
to form heptamers under normal conditions [39], although in
the crystal it formed a tetradecamer. It should be noted, how-
ever, that the structure of M. tuberculosis ClpP1 might not be
the predominant physiological assembly since there are two
ClpPs in M. tuberculosis (ClpP1 and ClpP2, Table 1) which
seem to be on the same operon and might form a hetero-oligo-
mer.
The unique feature in the structure of human ClpP is the
presence of an extended C-terminus with 28 additional residues
located on the periphery of the heptamer, forming a ﬂexible
loop which extends out of the surface of the oligomer. The
loop is unstructured and is not observed in the solved X-ray
structure of human ClpP (Figs. 1 and 2). This C-terminal
extension is found to aﬀect the assembly of human ClpP hep-
tamer since deletion of this C-terminus resulted in structurally
unstable ClpP [21]. However, the deletion also resulted in an
increased aﬃnity of human ClpP to human ClpX, suggesting
that the C-terminus might hinder the interaction between ClpX
and ClpP [21].
Based on these multiple ClpP structures from diﬀerent
organisms, it can be seen that the ClpP cylinder maintains
the same overall assembly and construction. Modiﬁcations
are then added to the ‘core’ ClpP structure to engineer speciﬁc
functions that are suitable for the varied cellular environments
of the diﬀerent organisms.3.2. ClpP mechanism of function
ClpP is a classical serine protease whereby each subunit in
the ClpP homotetradecamer has an active site consisting of
the three canonical residues: Ser, His, and Asp (Figs. 2A and
3). Hence, the ClpP homotetradecamer contains 14 active sites
within its proteolytic chamber. Fig. 2A shows the location of
the catalytic triad at the junction between the head and handle
domains in each ClpP monomer. For the case of the hetero
ClpPR complexes in plants and cyanobacteria, the number
of active sites would be reduced. It has been shown that
mutations in the handle region are often found to decrease
ClpP activity due to the close proximity of the active site to
the handle region, resulting in the disruption of the catalytic
triad alignment [42]. Systematic studies on ClpP substrate
cleaving speciﬁcity have not yet been published, however,
according to one report [36], E. coli ClpP was found to prefer-
entially cleave after charged and branched-chain amino acids.
There are indications that the catalytic residues undergo a
rearrangement to an active conﬁguration upon substrate bind-
ing [36].
The only access to the catalytic chamber is through the nar-
row axial pores which allow entry of small peptides of about 30
residues in length [15]. The N-terminal axial loops contribute
to the axial pores. The axial loops can be divided into two
parts [35–37]. There are 7–8 hydrophobic residues, termed
the axial pore lining, that line the axial pores followed by
about 9 residues, the axial protrusion, that protrude from
the apical surface of the ClpP cylinder (Fig. 2). These axial
loops are required for the interaction of ClpP with its cognate
ATPases [35,37]. Mutants with the ﬁrst seven N-terminal resi-
dues deleted from mature ClpP were shown to be unable to de-
grade folded protein substrates in the presence of the ATPases,
but exhibited higher peptidase activity, suggesting that the
truncations did not inactivate the protease but had disrupted
its interaction with the chaperones [37]. The increased pepti-
dase activity is probably due to the enlargement of the axial
pores resulting from the deletion of the N-terminal residues.
On the apical surface of ClpP, about 54 A˚ away from the ax-
ial pores, there are seven grooves of about 10 A˚ in diameter.
These grooves are mainly composed of conserved hydrophobic
residues and are thought to provide binding pockets for spe-
ciﬁc loop regions present in the structure of the chaperones.
These loop regions are highly conserved in AAA+ chaperones
that bind to ClpP [44] such as the ‘IGF’ loop in E. coli ClpX or
‘IGL’ loop in E. coli ClpA. Hence, the chaperone–protease
interaction is mainly mediated by loop–groove interactions
rather by interactions between large surfaces. This mode of
interaction might circumvent the symmetry mismatch that ex-
ists between ClpP, which has a sevenfold symmetry, and its
interacting chaperones, which typically have sixfold symmetry.
It is not known how many loop–groove contacts are main-
tained between ClpX hexamer and ClpP oligomer in an active
ClpXP complex. The symmetry mismatch between chaperone
rings and ClpP rings have been proposed to be an evolutionary
result to allow the rings to reciprocate or rotate about each
other, enhancing the rate of translocation of unfolded sub-
strates [45], although no experimental evidence for such rota-
tion is currently available. Alternatively, the loop–groove
interaction could provide the chaperone–protease complex
with more structural ﬂexibility that might be necessary for
the complex to achieve substrate protein unfolding, transloca-
tion, protein degradation, and peptide product release.
3756 A.Y.H. Yu, W.A. Houry / FEBS Letters 581 (2007) 3749–3757ClpP processively degrades substrates and generates pep-
tides of average length of about 7–8 residues [4,15]. The mech-
anisms by which unfolded polypeptides enter ClpP and how
the degraded products are released from the protease are still
poorly understood. Crystallographic data [34,36] indicate that
the substrate protein is probably captured close to the active
site by a hydrogen bonding network involving residues in b4
and b9 and that the interaction is further stabilized by hydro-
phobic interactions with the wall of the ClpP chamber. It is
proposed that the substrate will be horizontally positioned in
the proteolytic chamber near the equator of the ClpP cylinder
and oriented in a clockwise N to C direction when viewed from
the axial channel through which the substrate entered [36].
This would be in agreement with a C to N translocation of
substrates into the ClpP proteolytic chamber.
Diﬀerent hypotheses exist about the mechanism of product
release. One model proposes that the generated peptides exit
the ClpP proteolytic chamber by passive diﬀusion through
the same axial pores used for substrate entry [34,46,47]. How-
ever, this implies that the bound chaperones have to dissociate
from the ClpP cylinder to allow for peptide exit. Such a mech-
anism might be ineﬃcient and would probably render the deg-
radation of polypeptide chains nonprocessive. This mechanism
has been suggested for the proteasome in which the dissocia-
tion of the ATPase units has been reported to coincide with
product release [48]. The second model suggests that peptides
are released through side pores that are transiently formed at
the interface between the two heptameric ClpP rings. It has
been established that the handle region exhibits high plasticity
[37], and NMR studies further conﬁrmed that the E helices ex-
change between at least two structurally distinct conforma-
tions, suggesting the existence of transiently formed dynamic
side pores which could act as exit pores for degraded products
[42]. Biochemical data also conﬁrmed this model for peptide
exit. An alanine residue at position 153 on the E helix of
E. coli ClpP was mutated to cysteine, A153C, allowing the for-
mation of a disulﬁde bond between E helices of two subunits
from the two opposite heptameric ClpP rings. The crosslinking
of the two rings inhibited movements of the handle regions. A
small dipeptide was able to diﬀuse into the chamber of disul-
ﬁde-linked inactive ClpP but was trapped inside the chamber
under oxidizing condition. The trapped substrate was shown
to be released after the system was placed in reducing condi-
tions. The results strongly suggested that the equatorial re-
gions of the ClpP barrel provide the exit sites of degraded
products [42]. The observation that M. tuberculosis ClpP1
and human ClpP exist mainly as single heptameric rings
[23,39] and that human ClpP forms the double ring structure
only upon binding the chaperone ClpX [23], seems to further
support the peptide exit model through transiently formed
equatorial side pores.4. Concluding remarks
Understanding how the ClpP system functions has direct
implications on understanding the mechanism of function of
other more complex cylindrical proteases such as the protea-
some. ClpP shares many similarities with the proteasome both
functionally and structurally. The arrangement of subunits in
ClpP is strikingly analogous to that of eukaryotic and archaeal
20S proteasomes, which is composed of two heptameric b-sub-unit rings enclosing the active site sandwiched between 2 hep-
tameric rings of a subunits. Another protease HslV (ClpQ),
also known as the ‘bacterial proteasome’, exhibits analogous
packing except that the cylinder is composed of two hexameric
rings. The similarity in the cylindrical structural arrangement
probably underlines the commonality in the mechanism of
function of these proteases. Eﬀorts currently underway in sev-
eral laboratories should further enhance our understanding of
the mechanism of function of these degradative machines.
These ongoing eﬀorts might have direct clinical consequences
as ClpP has now been shown to be a legitimate antibacterial
drug target.
Acknowledgements: The authors thank Guillaume Thibault and Dr.
Anna Gribun for careful reading of the manuscript. We also thank
Jennifer K.W. Huen for help with Fig. 4. W.A.H. is Canadian Insti-
tutes of Health Research New Investigator. This work is supported
by a grant from the Canadian Institutes of Health Research.References
[1] Wong, P. and Houry, W.A. (2004) Chaperone networks in
bacteria: analysis of protein homeostasis in minimal cells. J.
Struct. Biol. 146, 79–89.
[2] Katayama-Fujimura, Y., Gottesman, S. and Maurizi, M.R.
(1987) A multiple-component, ATP-dependent protease from
Escherichia coli. J. Biol. Chem. 262, 4477–4485.
[3] Katayama, Y., Gottesman, S., Pumphrey, J., Rudikoﬀ, S., Clark,
W.P. and Maurizi, M.R. (1988) The two-component, ATP-
dependent Clp protease of Escherichia coli. Puriﬁcation, cloning,
and mutational analysis of the ATP-binding component. J. Biol.
Chem. 263, 15226–15236.
[4] Choi, K.H. and Licht, S. (2005) Control of peptide product sizes
by the energy-dependent protease ClpAP. Biochemistry 44,
13921–13931.
[5] Wojtyra, U.A., Thibault, G., Tuite, A. and Houry, W.A. (2003)
The N-terminal zinc binding domain of ClpX is a dimerization
domain that modulates the chaperone function. J. Biol. Chem.
278, 48981–48990.
[6] Peltier, J.B., Ytterberg, J., Liberles, D.A., Roepstorﬀ, P. and van
Wijk, K.J. (2001) Identiﬁcation of a 350-kDa ClpP protease
complex with 10 diﬀerent Clp isoforms in chloroplasts of
Arabidopsis thaliana. J. Biol. Chem. 276, 16318–16327.
[7] Schelin, J., Lindmark, F. and Clarke, A.K. (2002) The clpP
multigene family for the ATP-dependent Clp protease in the
cyanobacterium Synechococcus. Microbiology 148, 2255–2265.
[8] Stanne, T.M., Pojidaeva, E., Andersson, F.I. and Clarke, A.K.
(2007) Distinctive types of ATP-dependent Clp proteases in
cyanobacteria. J. Biol. Chem. 282, 14394–14402.
[9] Maurizi, M.R., Clark, W.P., Kim, S.H. and Gottesman, S. (1990)
Clp P represents a unique family of serine proteases. J. Biol.
Chem. 265, 12546–12552.
[10] Butler, S.M., Festa, R.A., Pearce, M.J. and Darwin, K.H. (2006)
Self-compartmentalized bacterial proteases and pathogenesis.
Mol. Microbiol. 60, 553–562.
[11] Keiler, K.C., Waller, P.R. and Sauer, R.T. (1996) Role of a
peptide tagging system in degradation of proteins synthesized
from damaged messenger RNA. Science 271, 990–993.
[12] Gottesman, S., Roche, E., Zhou, Y. and Sauer, R.T. (1998) The
ClpXP and ClpAP proteases degrade proteins with carboxy-
terminal peptide tails added by the SsrA-tagging system. Genes
Dev. 12, 1338–1347.
[13] Weber-Ban, E.U., Reid, B.G., Miranker, A.D. and Horwich, A.L.
(1999) Global unfolding of a substrate protein by the Hsp100
chaperone ClpA. Nature 401, 90–93.
[14] Gillet, R. and Felden, B. (2001) Emerging views on tmRNA-
mediated protein tagging and ribosome rescue. Mol. Microbiol.
42, 879–885.
[15] Thompson, M.W., Singh, S.K. and Maurizi, M.R. (1994)
Processive degradation of proteins by the ATP-dependent Clp
protease from Escherichia coli. Requirement for the multiple
A.Y.H. Yu, W.A. Houry / FEBS Letters 581 (2007) 3749–3757 3757array of active sites in ClpP but not ATP hydrolysis. J. Biol.
Chem. 269, 18209–18215.
[16] Gottesman, S., Maurizi, M.R. and Wickner, S. (1997) Regulatory
subunits of energy-dependent proteases. Cell 91, 435–438.
[17] Brotz-Oesterhelt, H. et al. (2005) Dysregulation of bacterial
proteolytic machinery by a new class of antibiotics. Nat. Med.
11, 1082–1087.
[18] Corydon, T.J. et al. (2000) Human and mouse mitochondrial
orthologs of bacterial ClpX. Mamm. Genome 11, 899–905.
[19] de Sagarra, M.R., Mayo, I., Marco, S., Rodriguez-Vilarino, S.,
Oliva, J., Carrascosa, J.L. and Casta n, J.G. (1999) Mitochondrial
localization and oligomeric structure of HClpP, the human
homologue of E. coli ClpP. J. Mol. Biol. 292, 819–825.
[20] von Heijne, G., Steppuhn, J. and Herrmann, R.G. (1989) Domain
structure of mitochondrial and chloroplast targeting peptides.
Eur. J. Biochem. 180, 535–545.
[21] Kang, S.G., Maurizi, M.R., Thompson, M., Mueser, T. and
Ahvazi, B. (2004) Crystallography and mutagenesis point to an
essential role for the N-terminus of human mitochondrial ClpP. J.
Struct. Biol. 148, 338–352.
[22] Kang, S.G., Ortega, J., Singh, S.K., Wang, N., Huang, N.N.,
Steven, A.C. and Maurizi, M.R. (2002) Functional proteolytic
complexes of the human mitochondrial ATP-dependent protease,
hClpXP. J. Biol. Chem. 277, 21095–21102.
[23] Kang, S.G., Dimitrova, M.N., Ortega, J., Ginsburg, A. and
Maurizi, M.R. (2005) Human mitochondrial ClpP is a stable
heptamer that assembles into a tetradecamer in the presence of
ClpX. J. Biol. Chem. 280, 35424–35432.
[24] Kirstein, J., Schlothauer, T., Dougan, D.A., Lilie, H., Tischen-
dorf, G., Mogk, A., Bukau, B. and Turgay, K. (2006) Adaptor
protein controlled oligomerization activates the AAA+ protein
ClpC. EMBO J. 25, 1481–1491.
[25] Peltier, J.B. et al. (2004) Clp protease complexes from photosyn-
thetic and non-photosynthetic plastids and mitochondria of
plants, their predicted three-dimensional structures, and func-
tional implications. J. Biol. Chem. 279, 4768–4781.
[26] Sjogren, L.L., Stanne, T.M., Zheng, B., Sutinen, S. and Clarke,
A.K. (2006) Structural and functional insights into the chloroplast
ATP-dependent Clp protease in Arabidopsis. Plant Cell 18, 2635–
2649.
[27] Erbse, A., Schmidt, R., Bornemann, T., Schneider-Mergener, J.,
Mogk, A., Zahn, R., Dougan, D.A. and Bukau, B. (2006) ClpS is
an essential component of the N-end rule pathway in Escherichia
coli. Nature 439, 753–756.
[28] Halperin, T., Zheng, B., Itzhaki, H., Clarke, A.K. and Adam, Z.
(2001) Plant mitochondria contain proteolytic and regulatory
subunits of the ATP-dependent Clp protease. Plant Mol. Biol. 45,
461–468.
[29] Majeran, W., Friso, G., van Wijk, K.J. and Vallon, O. (2005) The
chloroplast ClpP complex in Chlamydomonas reinhardtii contains
an unusual high molecular mass subunit with a large apical
domain. FEBS J. 272, 5558–5571.
[30] Majeran, W., Wollman, F.A. and Vallon, O. (2000) Evidence for
a role of ClpP in the degradation of the chloroplast cytochrome
b(6)f complex. Plant Cell 12, 137–150.
[31] Shikanai, T., Shimizu, K., Ueda, K., Nishimura, Y., Kuroiwa, T.
and Hashimoto, T. (2001) The chloroplast clpP gene, encoding a
proteolytic subunit of ATP-dependent protease, is indispensable
for chloroplast development in tobacco. Plant Cell Physiol. 42,
264–273.
[32] Kuroda, H. and Maliga, P. (2002) Overexpression of the clpP 50-
untranslated region in a chimeric context causes a mutant
phenotype, suggesting competition for a clpP-speciﬁc RNAmaturation factor in tobacco chloroplasts. Plant Physiol. 129,
1600–1606.
[33] Rudella, A., Friso, G., Alonso, J.M., Ecker, J.R. and van Wijk,
K.J. (2006) Downregulation of ClpR2 leads to reduced accumu-
lation of the ClpPRS protease complex and defects in chloroplast
biogenesis in Arabidopsis. Plant Cell 18, 1704–1721.
[34] Wang, J., Hartling, J.A. and Flanagan, J.M. (1997) The structure
of ClpP at 2.3 A resolution suggests a model for ATP-dependent
proteolysis. Cell 91, 447–456.
[35] Bewley, M.C., Graziano, V., Griﬃn, K. and Flanagan, J.M.
(2006) The asymmetry in the mature amino-terminus of ClpP
facilitates a local symmetry match in ClpAP and ClpXP
complexes. J. Struct. Biol. 153, 113–128.
[36] Szyk, A. and Maurizi, M.R. (2006) Crystal structure at 1.9A of
E. coli ClpP with a peptide covalently bound at the active site. J.
Struct. Biol. 156, 165–174.
[37] Gribun, A., Kimber, M.S., Ching, R., Sprangers, R., Fiebig,
K.M. and Houry, W.A. (2005) The ClpP double ring tetradeca-
meric protease exhibits plastic ring-ring interactions, and the N
termini of its subunits form ﬂexible loops that are essential for
ClpXP and ClpAP complex formation. J. Biol. Chem. 280, 16185–
16196.
[38] Vedadi, M. et al. (2007) Genome-scale protein expression and
structural biology of Plasmodium falciparum and related Apicom-
plexan organisms. Mol. Biochem. Parasitol. 151, 100–110.
[39] Ingvarsson, H., Mate, M.J., Hogbom, M., Portnoi, D., Ben-
aroudj, N., Alzari, P.M., Ortiz-Lombardia, M. and Unge, T.
(2007) Insights into the inter-ring plasticity of caseinolytic
proteases from the X-ray structure of Mycobacterium tuberculo-
sis ClpP1. Acta Crystallogr. D Biol. Crystallogr. 63, 249–259.
[40] Wang, J., Hartling, J.A. and Flanagan, J.M. (1998) Crystal
structure determination of Escherichia coli ClpP starting from an
EM-derived mask. J. Struct. Biol. 124, 151–163.
[41] Maurizi, M.R., Singh, S.K., Thompson, M.W., Kessel, M. and
Ginsburg, A. (1998) Molecular properties of ClpAP protease of
Escherichia coli: ATP-dependent association of ClpA and clpP.
Biochemistry 37, 7778–7786.
[42] Sprangers, R., Gribun, A., Hwang, P.M., Houry, W.A. and Kay,
L.E. (2005) Quantitative NMR spectroscopy of supramolecular
complexes: dynamic side pores in ClpP are important for product
release. Proc. Natl. Acad. Sci. USA 102, 16678–16683.
[43] Waller, R.F. and McFadden, G.I. (2005) The apicoplast: a review
of the derived plastid of apicomplexan parasites. Curr. Issues
Mol. Biol. 7, 57–79.
[44] Kim, D.Y. and Kim, K.K. (2003) Crystal structure of ClpX
molecular chaperone from Helicobacter pylori. J. Biol. Chem.
278, 50664–50670.
[45] Beuron, F., Maurizi, M.R., Belnap, D.M., Kocsis, E., Booy, F.P.,
Kessel, M. and Steven, A.C. (1998) At sixes and sevens:
characterization of the symmetry mismatch of the ClpAP chap-
erone-assisted protease. J. Struct. Biol. 123, 248–259.
[46] Thompson, M.W. and Maurizi, M.R. (1994) Activity and
speciﬁcity of Escherichia coli ClpAP protease in cleaving model
peptide substrates. J. Biol. Chem. 269, 18201–18208.
[47] Kim, Y.I., Burton, R.E., Burton, B.M., Sauer, R.T. and Baker,
T.A. (2000) Dynamics of substrate denaturation and translo-
cation by the ClpXP degradation machine. Mol. Cell 5, 639–
648.
[48] Babbitt, S.E. et al. (2005) ATP hydrolysis-dependent disassembly
of the 26S proteasome is part of the catalytic cycle. Cell 121, 553–
565.
[49] Henikoﬀ, S. and Henikoﬀ, J.G. (1993) Performance evaluation of
amino acid substitution matrices. Proteins 17, 49–61.
